Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Obesity (Silver Spring). 2016 Apr 1;24(5):1018–1026. doi: 10.1002/oby.21487

Table 1.

Considerations for experimental models and study designs commonly used in developmental programming research

Experimental Model Considerations Advantages Disadvantages
Animal
  • Common species for study: rats, mice, non-human primates, sheep, and guinea pigs

  • When translating findings: genetic similarities/differences to humans, polytocous and altricial species, proportional translation of intervention/exposure to humans

  • Timing of exposure, e.g. initiation prior to conception, early in gestation, or throughout gestation? Include weaning?

  • Low genetic variability + genetic models (knockdowns, knockouts, transgenics)

  • Highly controlled conditions (sleep cycle, diet, exercise, stress, etc.)

  • Implementation of adverse intrauterine exposure

  • Analysis of tissues

  • Low cost

  • Shorter gestation compared to human

  • Interpretation and translation for human relevance

Human
  • Timing of exposure, e.g. early, middle, late or all of gestation, breastfeeding

  • Tissue specific epigenetic signatures

  • Translational findings

  • Public health relevance

  • High interindividual variability

  • Lifestyle (un/healthy) effects on development of disease and modifications of epigenome

  • Ethical considerations for implementing/observing adverse intrauterine exposures and studying vulnerable populations

  • Limited tissue access

Unknown Exposure
Retrospective
  • Availability of birth records

  • Association of birth weight with adult onset diseases

  • Large sample size

  • Low cost

  • Assumption of birth outcome correlating to adverse exposure

  • Lack of causative evidence

  • Reliance on medical records and/or self-report

Known Exposure
Retrospective
  • Availability of retrospective data e.g. birth records and documentation of intrauterine exposures

  • Large sample size

  • Low cost

  • Potential for causative correlations

  • Reliance on medical records and/or self-report

Prospective and Retrospective
  • Availability to associate retrospective prospective data

  • Ability for in vivo assessments such as body composition, insulin sensitivity, methylation patterns, etc.

  • Limited by the lack of data on or during the specific intrauterine environment exposures

Longitudinal
  • Feasibility and ethical considerations in vulnerable populations, e.g. naturally occurring adverse exposures through famine or other environmental disaster

  • Ability to evaluate intrauterine exposures in real time and respective fetal, infant and adolescent outcomes

  • High cost

  • Difficulty with long-term retention

Interventional
  • Mendelian randomization

  • Past exposures and current epigenome

  • Parallel or crossover design

  • Timing of intervention

  • Intervention must be generally regarded as safe

  • Ability to control for covariates through randomization

  • High cost

  • Resource intensive